Injectable Cabanuva, Cabotegravir, Rilpivirine
Cabenuva: Injectable Cabanuva, Cabotegravir, Rilpivirine · Aug 9–15, 2026
NewThe campaign encourages listeners who may be considering an injectable treatment to look more closely at Cabenuva and decide if it is the right time for a different treatment.
13-week activity
Public campaign reads by observed week
Renewal signals
No recurring promo code was observed.
Shows
Where the campaign appearedRepresentative reads
Examples across the campaignExample transcript
The read that best represents this campaign's recurring script
This reminder is brought to you by Injectable Cabanuva, Cabotegravir, Rilpivirine. You may have been thinking about an injectable treatment. It can be a moment to think about what matters, like considering if it's right for you. Maybe it's time to look a little more closely at Cabanuva. You can see what it's about and decide if it's the right time to think about a different treatment. Get the facts on Cabanuva at Cabanuva.com. That's C-A-B-E-N-U-V-A dot com.
More campaigns from Cabenuva
Other published campaigns from this sponsor
The campaign promotes Injectable Cabanuva by encouraging listeners to consider if an injectable treatment is right for them and to evaluate Cabanuva as a different treatment option.
Cabenuva is an injectable HIV treatment regimen that offers the convenience of not requiring daily pills for HIV-1 infection.
The campaign promotes Injectable Cabenuva by encouraging listeners to check insurance coverage and utilize an access coordinator for guidance on discussing injectable treatment with their doctor.
These signals describe observed podcast advertising activity. Per-read dollar figures are directional current placement proxies—not historical campaign spend, reach, conversions, or return on investment.